Literature DB >> 21658857

Use of implanted markers and interportal adjustment with real-time tracking radiotherapy system to reduce intrafraction prostate motion.

Shinichi Shimizu1, Yasuhiro Osaka, Nobuo Shinohara, Ataru Sazawa, Kentaro Nishioka, Ryusuke Suzuki, Rikiya Onimaru, Hiroki Shirato.   

Abstract

PURPOSE: Interportal adjustment was applied to patients with prostate cancer using three fiducial markers and two sets of fluoroscopy in a real-time tumor-tracking radiotherapy (RTRT) system. The incidence of table position adjustment required to keep intrafractional uncertainty within 2.0 mm was investigated in this study. METHODS AND MATERIALS: The coordinates of the center of gravity of the three fiducial markers were measured at the start of every portal irradiation in intensity-modulated radiotherapy (IMRT) with seven ports. The table position was adjusted to the planned position if the discrepancy was larger than 2.0 mm in the anterior-posterior (AP), cranial-caudal (CC), or left-right (LR) directions. In total, we analyzed 4,541 observations in 20 patients who received 70 Gy in 30 fractions (7.6 times a day on average).
RESULTS: The incidence of table position adjustment at 10 minutes from the initial setup of each treatment was 14.2%, 12.3%, and 5.0% of the observations in the AP, CC, and LR directions, respectively. The accumulated incidence of the table position adjustment was significantly higher at 10 minutes than at 2 minutes for AP (p = 0.0033) and CC (p = 0.0110) but not LR (p = 0.4296). An adjustment greater than 5 mm was required at least once in the treatment period in 11 (55%) patients.
CONCLUSIONS: Interportal adjustment of table position was required in more than 10% of portal irradiations during the 10-minute period after initial setup to maintain treatment accuracy within 2.0 mm.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21658857     DOI: 10.1016/j.ijrobp.2011.04.043

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  13 in total

1.  Scanned ion beam therapy for prostate carcinoma: Comparison of single plan treatment and daily plan-adapted treatment.

Authors:  Sebastian Hild; Christian Graeff; Antoni Rucinski; Klemens Zink; Gregor Habl; Marco Durante; Klaus Herfarth; Christoph Bert
Journal:  Strahlenther Onkol       Date:  2015-11-27       Impact factor: 3.621

2.  Dose impact of rectal gas on prostatic IMRT and VMAT.

Authors:  Motoharu Sasaki; Hitoshi Ikushima; Masahide Tominaga; Takeshi Kamomae; Taro Kishi; Masataka Oita; Masafumi Harada
Journal:  Jpn J Radiol       Date:  2015-11-17       Impact factor: 2.374

3.  A simulation study on the dosimetric benefit of real-time motion compensation in spot-scanning proton therapy for prostate.

Authors:  Yusuke Fujii; Taeko Matsuura; Seishin Takao; Yuka Matsuzaki; Takaaki Fujii; Naoki Miyamoto; Kikuo Umegaki; Kentaro Nishioka; Shinichi Shimizu; Hiroki Shirato
Journal:  J Radiat Res       Date:  2017-07-01       Impact factor: 2.724

4.  Analysis of inter- and intra fractional partial bladder wall movement using implanted fiducial markers.

Authors:  Kentaro Nishioka; Shinichi Shimizu; Nobuo Shinohara; Yoichi M Ito; Takashige Abe; Satoru Maruyama; Norio Katoh; Rumiko Kinoshita; Takayuki Hashimoto; Naoki Miyamoto; Rikiya Onimaru; Hiroki Shirato
Journal:  Radiat Oncol       Date:  2017-03-01       Impact factor: 3.481

5.  Prospective phase II study of image-guided local boost using a real-time tumor-tracking radiotherapy (RTRT) system for locally advanced bladder cancer.

Authors:  Kentaro Nishioka; Shinichi Shimizu; Nobuo Shinohara; Yoichi M Ito; Takashige Abe; Satoru Maruyama; Rumiko Kinoshita; Keiichi Harada; Noboru Nishikawa; Naoki Miyamoto; Rikiya Onimaru; Hiroki Shirato
Journal:  Jpn J Clin Oncol       Date:  2013-12-02       Impact factor: 3.019

6.  Longitudinal comparison of quality of life after real-time tumor-tracking intensity-modulated radiation therapy and radical prostatectomy in patients with localized prostate cancer.

Authors:  Nobuo Shinohara; Satoru Maruyama; Shinichi Shimizu; Kentaro Nishioka; Takashige Abe; Kanako C-Hatanaka; Koji Oba; Katsuya Nonomura; Hiroki Shirato
Journal:  J Radiat Res       Date:  2013-05-09       Impact factor: 2.724

7.  Early results of urethral dose reduction and small safety margin in intensity-modulated radiation therapy (IMRT) for localized prostate cancer using a real-time tumor-tracking radiotherapy (RTRT) system.

Authors:  Shinichi Shimizu; Kentaro Nishioka; Ryusuke Suzuki; Nobuo Shinohara; Satoru Maruyama; Takashige Abe; Rumiko Kinoshita; Norio Katoh; Rikiya Onimaru; Hiroki Shirato
Journal:  Radiat Oncol       Date:  2014-05-21       Impact factor: 3.481

8.  Inter-fraction movements of the prostate and pelvic lymph nodes during IGRT.

Authors:  Ulrika Björeland; Joakim Jonsson; Magnus Alm; Lars Beckman; Tufve Nyholm; Camilla Thellenberg-Karlsson
Journal:  J Radiat Oncol       Date:  2018-11-28

9.  Correlation between intrafractional motion and dosimetric changes for prostate IMRT: Comparison of different adaptive strategies.

Authors:  Nami Saito; Daniela Schmitt; Mark Bangert
Journal:  J Appl Clin Med Phys       Date:  2018-06-03       Impact factor: 2.102

10.  The urethral position may shift due to urethral catheter placement in the treatment planning for prostate radiation therapy.

Authors:  Yasuhiro Dekura; Kentaro Nishioka; Takayuki Hashimoto; Naoki Miyamoto; Ryusuke Suzuki; Takaaki Yoshimura; Ryuji Matsumoto; Takahiro Osawa; Takashige Abe; Yoichi M Ito; Nobuo Shinohara; Hiroki Shirato; Shinichi Shimizu
Journal:  Radiat Oncol       Date:  2019-12-12       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.